The More Life Company Advancing US Compounded Pharmaceutical Commercialization Pathway for Quicksome™
Strategic LOI advances U.S. compounding capability for a growing portfolio of potential Quicksome-enabled pharmaceutical applications

Registration is open for our 2026 Annual General Meeting
RegisterViewStrategic LOI advances U.S. compounding capability for a growing portfolio of potential Quicksome-enabled pharmaceutical applications

Tell us a little about your organization and what you are interested in exploring.